… Prostate cancer (PCa) is the most commonly diagnosed noncutaneous malignancy and
second leading cause of cancer… ) activity, since disease progression is fundamentally reliant on …

… the phenomenon of tumour progression. The unusually low proportion of metastatic prostate
cancers is readily explained by the large proportion of small-volume tumours in this organ. …

… prostate cancer have already had or are now experiencing recurrence. If approximately
200,000 patients are diagnosed with prostate cancer … PSA only early progression. Clearly this is …

… during prostate cancer (PC) progression may enable researchers to develop targeted
therapeutic strategies for advanced disease. PC progression … factors in cancer progression. Our …

… the development and progression of prostate cancer is not … the risk of prostate cancer and
may affect its rate of progression. … any conventional treatment for prostate cancer, our findings …

… genes involved in progression of prostate cancer, molecular markers may offer additional
hallmarks of cancer progression and our failure to cure this all-too-common cancer. So far, …

… tumor microenvironment during prostate cancer progression. Normal prostate epithelial cells
… Prostate cancer cells corrupt cancer associated fibroblasts (CAFS) to activate the Warburg …

… that IL-6 is involved in the androgen-independent progression of prostate cancer. IL-6
receptor is also expressed in both prostate cancer tissues and prostate cancer cell lines. IL-6 is a …

… prostate cancer, we screened 667 miRNAs in serum samples from patients with metastatic (n
= 7) and localized prostate cancer … set taken from different prostate cancer risk groups. Most …

… an important mechanism in prostate cancer for inactivation of … ) of genes linked to prostate
cancer progression. Recently, … growth factors with prostate cancer progression tend toward …